IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS - ANVISA Registration 10077090112

Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RED BLOOD CELL REAGENTS/ENZYME-TREATED RED BLOOD CELL REAGENTS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10077090112 and manufactured by manufacturer not specified. The registration is held by FRESENIUS HEMOCARE BRASIL LTDA. with validity until Feb 28, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including IMMUCOR, INC, MEDION DIAGNOSTICS GRIFOLS AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.